Zu den Inhalten springen
, 03.05.2017

Theranostics of prostate cancer with PSMA radiogands


The introduction of peptide-based small radioligands targeting the prostate specific membrane antigen (PSMA) has had a tremendous impact on the diagnosis and treatment of prostate cancer (PCa) in recent years.


Back